Final ID: P-433
Correnti Jacob, Ai Yong, Gladwin Mark, Xue Fengtian, Rose Jason, Demartino Anthony
Angiotensin II vascular abnormalities in 32.5% of 3322 patients with essential hypertension(EH): Use of angiotensin II analogue, saralasin.Anderson Gunnar